Linda li's most recent trade in CSX Corp. was a trade of 4,455 Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CSX | Linda H. Riefler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 4,455 | 32,450 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Linda Llewelyn | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 191,500 | 334,763 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Linda Llewelyn | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 13,195 | 347,958 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Linda Llewelyn | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.75 per share. | 25 Feb 2026 | 4,471 | 343,487 (0%) | 0% | 1.7 | 7,814 | Common Stock |
| Waters | Linda Baddour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 57 | 57 | - | - | Stock Option (Right to Buy) | |
| Waters | Linda Baddour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 23 | 2,899 (0%) | 0% | 0 | Common Stock | |
| Coeur Mining Inc | Linda L. Adamany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2026 | 5,247 | 244,928 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Entegris Inc | Linda LaGorga | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 91.63 per share. | 19 Feb 2026 | 11,438 | 45,248 (0%) | 0% | 91.6 | 1,048,064 | Common Stock |
| Entegris Inc | Linda LaGorga | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 135.00 per share. | 19 Feb 2026 | 11,438 | 33,810 (0%) | 0% | 135 | 1,544,130 | Common Stock |
| Entegris Inc | Linda LaGorga | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2026 | 11,438 | 11,438 | - | - | Employee Stock Option (Right to Buy) | |
| Entegris Inc | Linda LaGorga | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 8,840 | 36,760 (0%) | 0% | 0 | Common Stock | |
| Entegris Inc | Linda LaGorga | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.67 per share. | 19 Feb 2026 | 2,950 | 33,810 (0%) | 0% | 132.7 | 391,377 | Common Stock |
| Astronics Corp | Linda G. O’Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 1,533 | 21,372 (0%) | 0% | 0 | $.01 PV Com Stk | |
| HNI Corp | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 50.14 per share. | 18 Feb 2026 | 1,080 | 14,777 (0%) | 0% | 50.1 | 54,151 | Common Stock |
| HNI Corp | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 50.14 per share. | 18 Feb 2026 | 349 | 13,697 (0%) | 0% | 50.1 | 17,499 | Common Stock |
| Avadel Pharma PLC (ADR) | Linda S. Palczuk | Director | Sale or transfer of securities back to the company at price $ 21.00 per share. | 12 Feb 2026 | 78,905 | 0 (0%) | 0% | 21 | 1,657,005 | Ordinary Shares |
| Avadel Pharma PLC (ADR) | Linda S. Palczuk | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Linda S. Palczuk | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 42,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Linda S. Palczuk | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 42,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Linda S. Palczuk | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 42,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Linda S. Palczuk | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 33,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Linda S. Palczuk | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Linda S. Palczuk | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 11,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Linda S. Palczuk | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 11,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Emergent Biosolutions Inc | Richard S. Lindahl | EVP, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 10.92 per share. | 06 Feb 2026 | 46,155 | 245,342 (0%) | 0% | 10.9 | 504,013 | Common Stock |
| Emergent Biosolutions Inc | Richard S. Lindahl | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.92 per share. | 06 Feb 2026 | 5,642 | 239,700 (0%) | 0% | 10.9 | 61,611 | Common Stock |
| Dayforce | Linda P. Mantia | Director | Sale or transfer of securities back to the company at price $ 70.00 per share. | 04 Feb 2026 | 22,861 | 0 (0%) | 0% | 70 | 1,600,270 | Common Stock |
| Dayforce | Linda P. Mantia | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Feb 2026 | 4,744 | 0 | - | - | Options (Right to Purchase) | |
| Dayforce | Linda P. Mantia | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Feb 2026 | 3,869 | 0 | - | - | Options (Right to Purchase) | |
| Dayforce | Linda P. Mantia | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Feb 2026 | 2,721 | 0 | - | - | Options (Right to Purchase) | |
| Dayforce | Linda P. Mantia | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Feb 2026 | 2,380 | 0 (0%) | 0% | - | Common Stock | |
| Manhattan Associates Inc | Linda C. Pinne | SVP, Global Corp Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 2,050 | 41,657 (0%) | 0% | 0 | Common Stock | |
| Eagle Bancorp Montana Inc | Linda M. Chilton | SVP-Chief Retail Offcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 325 | 13,470 (0%) | 0% | 0 | Common Stock | |
| Manhattan Associates Inc | Linda C. Pinne | SVP, Global Corp Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 151.01 per share. | 31 Jan 2026 | 1,292 | 39,607 (0%) | 0% | 151.0 | 195,105 | Common Stock |
| PotlatchDeltic Corp | Linda Breard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jan 2026 | 31,958 | 0 (0%) | 0% | - | Common Stock | |
| RAPT Therapeutics Inc | Linda Kozick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 4,956 | 4,956 (0%) | 0% | 0 | Common Stock | |
| Virginia National Bankshares Corp | Linda M. Houston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 1,100 | 14,127 | - | 0 | Common Stock | |
| Danaher | Linda Hefner Filler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 13 | 8,916 | - | - | Phantom shares | |
| Cincinnati Financial | Linda W. Clement-Holmes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 847 | 17,987 (0%) | 0% | 0 | Common Stock | |
| Visa | Linda J. Rendle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2026 | 861 | 861 | - | - | Restricted Stock Units | |
| Manhattan Associates Inc | Linda C. Pinne | SVP, Global Corp Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 798 | 41,697 (0%) | 0% | 0 | Common Stock | |
| Manhattan Associates Inc | Linda C. Pinne | SVP, Global Corp Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 217 | 41,914 (0%) | 0% | 0 | Common Stock | |
| JPMC | Linda B. Bammann | Director | Grant, award, or other acquisition of securities at price $ 306.68 per share. | 20 Jan 2026 | 913 | 83,455 (0%) | 0% | 306.7 | 280,000 | Common Stock |
| Eversource Energy | Linda Dorcena Forry | Trustee | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 2,581 | 14,087 (0%) | 0% | 0 | Common Shares, $5.00 par value | |
| CNO Fin Grp Inc | Linda T. Gibson | Director | Grant, award, or other acquisition of securities at price $ 42.10 per share. | 15 Jan 2026 | 1,243 | 1,243 (0%) | 0% | 42.1 | 52,330 | Common Stock |
| Ralph Lauren | Linda Findley Kozlowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 1 | 10,560 (0%) | 0% | 0 | Class A Common Stock | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Linda Marban | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 7,500 | 7,500 | - | - | Restricted Stock Units | |
| CF Industries | Linda M. Dempsey | VP, Public Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 2,562 | 19,255 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| CF Industries | Linda M. Dempsey | VP, Public Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.26 per share. | 05 Jan 2026 | 697 | 16,693 (0%) | 0% | 80.3 | 55,941 | Common stock, par value $0.01 per share |
| Compass Therapeutics Inc | Richard S. Lindahl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Norwegian Cruise Line | Linda P. Jojo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 13,169 | 20,871 (0%) | 0% | 0 | Common Stock | |
| Washington Federal Inc | Linda S. Brower | Director | Grant, award, or other acquisition of securities at price $ 32.03 per share. | 02 Jan 2026 | 3,310 | 63,758 (0%) | 0% | 32.0 | 106,019 | Common Stock |
| PPL | Linda G. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 1,246 | 18,379 | - | - | Stock Unit (DDCP) | |
| Washington Federal Inc | Linda S. Brower | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.03 per share. | 02 Jan 2026 | 993 | 62,765 (0%) | 0% | 32.0 | 31,806 | Common Stock |
| Northwestern Corp | Linda G. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 64.54 per share. | 02 Jan 2026 | 852 | 32,632 (0%) | 0% | 64.5 | 54,988 | Common Stock |
| Waters | Linda Baddour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 828 | 828 | - | - | Stock Option (Right to Buy) | |
| Globe Life | Linda L. Addison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 723 | 20,406 (0%) | 0% | 0 | Common Stock | |
| Atlantic Union Bankshares Corp | Linda V. Schreiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 567 | 24,455 (0%) | 0% | 0 | Common Stock | |
| CF Industries | Linda M. Dempsey | VP, Public Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.13 per share. | 02 Jan 2026 | 363 | 17,390 (0%) | 0% | 80.1 | 29,087 | Common stock, par value $0.01 per share |
| Waters | Linda Baddour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 307 | 2,876 (0%) | 0% | 0 | Common Stock | |
| Chart Ind Inc | Linda A. Harty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 193 | 14,358 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Edison International | Linda Gillespie Stuntz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 1,158 | 9,436 (0%) | 0% | - | Common Stock | |
| Edison International | Linda Gillespie Stuntz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 1,158 | 23,834 | - | - | Deferred Stock Unit | |
| Thermon Grp Holdings Inc | Linda A. Dalgetty | Director | Grant, award, or other acquisition of securities at price $ 37.16 per share. | 01 Jan 2026 | 740 | 34,053 (0%) | 0% | 37.2 | 27,498 | Common Stock |
| Omnicom Group | Linda Johnson Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 635 | 12,849 (0%) | 0% | 0 | Common Stock, par value $0.15 per share | |
| American International | Linda A. Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 452 | 43,901 | - | - | Deferred Stock Unit | |
| American International | Linda A. Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 226 | 44,127 | - | - | Deferred Stock Unit | |
| AutoZone | Linda A. Goodspeed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 91 | 2,986 (0%) | 0% | 0 | Common Stock | |
| Edison International | Linda Gillespie Stuntz | Director | Sale or transfer of securities back to the company at price $ 72.50 per share. | 01 Jan 2026 | 2 | 9,434 (0%) | 0% | 72.5 | 145 | Common Stock |
| Solid Power Inc (Class A) | Linda C. Heller | CFO, Treasurer, & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.28 per share. | 31 Dec 2025 | 26,605 | 1,803,587 | - | 4.3 | 113,869 | Common Stock |
| Exelon | Linda P. Jojo | Director | Grant, award, or other acquisition of securities at price $ 43.87 per share. | 31 Dec 2025 | 940 | 54,696 | - | 43.9 | 41,238 | Common stock- deferred stock units |
| Movado Grp Inc | Linda Feeney | SVP, Principal Acct. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 35 | 536 | - | - | Phantom Stock Unit | |
| Consolidated Water Co. Ltd | Linda Beidler-D’Aguilar | Director | Grant, award, or other acquisition of securities at price $ 24.83 per share. | 15 Dec 2025 | 1,968 | 20,799 (0%) | 0% | 24.8 | 48,865 | Common Stock |
| Clorox | Linda J. Rendle | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.83 per share. | 12 Dec 2025 | 829 | 201,161 (0%) | 0% | 102.8 | 85,246 | Common Stock |
| CSW Industrials Inc | Linda A. Livingstone | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 630 | 12,283 (0%) | 0% | 0 | Common Stock | |
| HNI Corp | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2025 | 13,348 | 13,348 (0%) | 0% | - | Common Stock | |
| Northrim Bancorp Inc | Linda C. Thomas | Director | Purchase of securities on an exchange or from another person at price $ 24.95 per share. | 10 Dec 2025 | 800 | 5,488 (0%) | 0% | 25.0 | 19,960 | Common Stock |
| UL Soln Inc (Class A) | Linda S. Chapin | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 4 | 2,915 | - | - | Restricted Stock Units | |
| UL Soln Inc (Class A) | Linda S. Chapin | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 4 | 2,751 | - | - | Restricted Stock Units | |
| Editas Medicine Inc | Burkly Linda C. | EVP, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 2.15 per share. | 03 Dec 2025 | 713 | 68,777 (0%) | 0% | 2.2 | 1,535 | Common Stock |
| Health Catalyst Inc | Linda Llewelyn | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.90 per share. | 01 Dec 2025 | 9,762 | 143,263 (0%) | 0% | 2.9 | 28,312 | Common Stock |
| Bunge Ltd | Linda P. Jojo | Director | Grant, award, or other acquisition of securities at price $ 96.44 per share. | 01 Dec 2025 | 18 | 2,571 (0%) | 0% | 96.4 | 1,736 | Common Stock |
| MSCI | Linda H. Riefler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2025 | 6 | 20,589 (0%) | 0% | 0 | Common Stock | |
| Interpublic Group | Linda S. Sanford | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Nov 2025 | 53,975 | 0 (0%) | 0% | - | Common Stock | |
| Verint Systems Inc | Linda M. Crawford | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Nov 2025 | 18,553 | 0 (0%) | 0% | - | Common Stock | |
| Verint Systems Inc | Linda M. Crawford | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 8,980 | 0 | - | - | Restricted Stock Units | |
| Verint Systems Inc | Linda M. Crawford | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 8,980 | 8,980 (0%) | 0% | - | Common Stock | |
| Verint Systems Inc | Linda M. Crawford | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Nov 2025 | 8,980 | 0 (0%) | 0% | - | Common Stock | |
| Astec Ind Inc | Linda I. Knoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2025 | 10 | 12,115 (0%) | 0% | 0 | Common Stock | |
| BGC Grp Inc (Class A) | Linda A. Bell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 5,447 | 41,044 (0%) | 0% | 0 | Class A Common Stock, par value $0.01 per share | |
| Astrana Health Inc | Linda Marsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 20,000 | 0 | - | - | Stock Option (right to Buy) | |
| Astrana Health Inc | Linda Marsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.20 per share. | 03 Nov 2025 | 20,000 | 103,641 (0%) | 0% | 18.2 | 364,000 | Common Stock |
| Astrana Health Inc | Linda Marsh | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.99 per share. | 03 Nov 2025 | 11,033 | 92,608 (0%) | 0% | 33.0 | 363,979 | Common Stock |
| Eagle Bancorp Montana Inc | Linda M. Chilton | SVP-Chief Retail Offcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2025 | 2,627 | 13,145 (0%) | 0% | 0 | Common Stock | |
| Danaher | Linda Hefner Filler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 13 | 8,903 | - | - | Phantom shares | |
| Parker-Hannifin | Linda A. Harty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2025 | 258 | 5,359 (0%) | 0% | 0 | Restricted Stock Units | |
| KORU Medical Systems Inc | Linda M. Tharby | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 4.08 per share. | 16 Oct 2025 | 29,463 | 1,052,626 (2%) | 0% | 4.1 | 120,209 | Common Stock |
| Emergent Biosolutions Inc | Richard S. Lindahl | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.60 per share. | 15 Oct 2025 | 4,995 | 291,497 (0%) | 0% | 9.6 | 47,952 | Common Stock |
| Ralph Lauren | Linda Findley Kozlowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2025 | 1 | 10,558 (0%) | 0% | 0 | Class A Common Stock |